ArticleScientific reports2023
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan.
Yuko Kanbayashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it